There are several strategies that tumor cells employ during immune evasion, some of which include MHC class I structural alterations/downregulation, mutations of Fas or TRAIL and inhibition of T cell receptors and/or development of Treg [168,169,170]. This evidence concerns the gene FAS and neoplasm.